INTELLIGENCE IN ACTION

Patients, Pocketbooks and a Podcast on Prescription Price Transparency

August 01, 2018

The need for greater price transparency in healthcare is all over the news. Policy makers across the country have taken up the cause. Patients are demanding real change, as healthcare costs continue to rise and hit pocketbooks hard. Given that Surescripts processes nearly 5 million electronic prescriptions each day, we’re focused on leveraging technology to improve prescription price transparency specifically. Americans spent $425 billion on prescriptions in 2015, a more than 12 percent increase from 2014. And the nation’s spending on medicines is forecasted to reach $610-640 billion in 2020.

In a recent Becker’s Healthcare podcast, Surescripts Chief Executive Officer Tom Skelton talked about how the Surescripts Network Alliance is taking prescription price transparency from hot topic to healthcare reality. He also talked about why.

“We’re trying to step back and look at things more holistically to ensure we’re addressing issues that may be impacting medication adherence,” Skelton said. “We know that ten percent of people who abandon their prescriptions do so because of cost. We also have data that shows that about 40 percent of patients will abandon treatment when a prior authorization is required.”

Tom Skelton | Becker's Hospital Review

For more perspective on the criticality of price transparency, interoperability and more, check out the article and podcast

Related Articles

May 21, 2019

An Urgent Call for Transformation: Prescribers Need Better Information and a Streamlined Specialty Prescribing Process

Most likely, you or someone you love has been impacted by a complex or chronic illness like cancer or multiple sclerosis. Sadly, these diseases—and the cost of medications to treat them—are on the rise. More than half of specialty drugs cost in excess of $100,000 a year. As a result, spending on branded specialty medications is rising by 10 percent a year and is projected to surpass half of all medication spending by 2022, even though these drugs comprise just a fraction of all prescribed medications.

Read more...
May 20, 2019

Federal Government Issues Final Rule: Part D Plans Must Adopt a Real Time Benefit Tool

On May 16, the Centers for Medicare and Medicaid Services (CMS) issued its final rule: Medicare Advantage and Part D Drug Pricing Final Rule (CMS-4180-F).

We’ve been closely following this proposal as it relates to e-prescribing and the Part D prescription drug plan in particular. The rule is designed to accelerate the use of Real Time Benefit Tools (RTBTs), such as Surescripts Real-Time Prescription Benefit.

Read more...
April 15, 2019

Older, Sicker Patients Will Benefit from Real-Time Benefit Tools, So Let’s Not Delay Using Them.

Healthcare costs are increasingly prohibitive for too many Americans, and these costs can hit older Americans especially hard. That’s why we applaud the Centers for Medicare & Medicaid Services (CMS) proposed rule on real-time benefit tools (RTBT). Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX